Skip to main content
Alvaro Restrepo, MD, Oncology, McAllen, TX

AlvaroRestrepoMD

Oncology McAllen, TX

Physician

Are you Dr. Restrepo?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 99 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    1901 S 2nd St
    McAllen, TX 78503
    Phone+1 956-687-5150
    Fax+1 956-687-9546

Summary

  • Dr. Alvaro Restrepo, MD is an oncologist in McAllen, Texas. He is currently licensed to practice medicine in Texas and Florida. He is affiliated with Rio Grande Regional Hospital, Doctor's Hospital at Renaissance, and Mission Regional Medical Center.

Education & Training

  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 1994 - 1997
  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemResidency, Internal Medicine, 1991 - 1993
  • Institute of Health Sciences Medellin Faculty of Medicine
    Institute of Health Sciences Medellin Faculty of MedicineClass of 1987

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 1992 - 2025
  • TX State Medical License
    TX State Medical License 2001 - 2025
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Two-Time Breast Cancer Survivor Shares Importance of Mammograms
    Two-Time Breast Cancer Survivor Shares Importance of MammogramsOctober 28th, 2021
  • Convince Me: Why Should I Participate in a Clinical Trial?
    Convince Me: Why Should I Participate in a Clinical Trial?June 12th, 2018